ATHENA (GOG-3020/ENGOT-ov45): any randomized, phase 3 test to judge rucaparib as monotherapy (ATHENA-MONO) and also rucaparib along with nivolumab (ATHENA-COMBO) because servicing remedy right after frontline platinum-based chemotherapy within ovarian cancers.